journal article·2024-11

Spiderweb‐Shaped Iron‐Coordinated Polymeric Network as the Novel Coating on Microneedles for Transdermal Drug Delivery Against Infectious Wounds

Xinwei Fu, Tao Zhang, Chuanlan Xia, Shan Du, Bo Wang, Zhensen Pan, Yunlong Yu, Peng Xue, Bin Wang, Yuejun Kang

Advanced Healthcare Materials· Volume 13· Issue 29
Publisher page

Abstract

Abstract Coated microneedles (CMNs) are a minimally invasive platform for immediate‐release transdermal drug delivery. However, the practical applications of CMNs have been significantly hindered by the challenges associated with complex formulations, single function, and limited drug loading capacity. This study has developed a spiderweb‐shaped iron‐coordinated polymeric nanowire network (Fe‐IDA NWs). The resulting Fe‐IDA NWs are endowed with a certain viscosity due to the synergy of multiple supramolecular interactions. This allows them to replace traditional polymeric thickeners as microneedle coatings. The Fe‐IDA NWs‐coated microneedles (Fe‐IDA MNs) display rapid disintegration in the skin model, which also enables the swift diffusion of Fe‐IDA NWs and their payloads into the deeper skin layers. Additionally, Fe‐IDA MNs exhibit desirable enzymatic activity and potential antibacterial ability. Thus, Fe‐IDA MNs can enhance the therapeutic efficacy against wound infection through synergistic effects, and avoid the overly complicated formulation and the release of nontherapeutic molecules of conventional CMNs. As a proof‐of‐concept, Fe‐IDA MNs loaded with chlorin e6 showed a synergistic chemodynamic‐photodynamic antibacterial effect in a methicillin‐resistant Staphylococcus aureus‐infected wound model in mice. Collectively, this work has significant implications for the future of CMNs‐based transdermal drug delivery systems and expands the application fields of metal coordination polymer (MCP) materials.
Source: crossref · Quality: baseline

Research context

OpenAlex topics: Advancements in Transdermal Drug Delivery · Advanced Drug Delivery Systems · Wound Healing and Treatments

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Key Laboratory of Luminescence Analysis and Molecular Sensing School of Materials and Energy Southwest University Chongqing 400715 China

Yibin Academy of Southwest University Yibin 644000 China

Institute of Burn Research Southwest Hospital and State Key Lab of Trauma Third Military Medical University (Army Medical University) Chongqing 400038 China

Funding

National Natural Science Foundation of China · National Key Research and Development Program of China

References (48)

Show source-provided references
1. 10.1016/j.actbio.2017.10.03010.1016/j.actbio.2017.10.030 ↗
2. 10.1016/j.vaccine.2015.02.07410.1016/j.vaccine.2015.02.074 ↗
3. 10.1016/j.biopha.2017.07.01910.1016/j.biopha.2017.07.019 ↗
4. 10.1021/acs.biomac.1c0132510.1021/acs.biomac.1c01325 ↗
5. 10.1016/j.bios.2018.08.01010.1016/j.bios.2018.08.010 ↗
6. 10.1016/j.jconrel.2017.02.01110.1016/j.jconrel.2017.02.011 ↗
7. 10.1016/j.jconrel.2020.12.01910.1016/j.jconrel.2020.12.019 ↗
8. 10.1016/j.apsb.2021.03.00310.1016/j.apsb.2021.03.003 ↗
9. 10.1016/j.mtbio.2023.10057910.1016/j.mtbio.2023.100579 ↗
10. 10.1016/j.jconrel.2017.03.38310.1016/j.jconrel.2017.03.383 ↗
11. 10.1016/j.addr.2012.04.00510.1016/j.addr.2012.04.005 ↗
12. 10.1016/j.jconrel.2006.10.01710.1016/j.jconrel.2006.10.017 ↗
13. 10.1007/s11095-007-9286-410.1007/s11095-007-9286-4 ↗
14. 10.1016/j.jconrel.2009.06.02910.1016/j.jconrel.2009.06.029 ↗
15. 10.1016/S0168-3659(04)00171-310.1016/S0168-3659(04)00171-3 ↗
16. 10.1016/j.jconrel.2009.10.01310.1016/j.jconrel.2009.10.013 ↗
17. 10.1016/j.jddst.2018.03.02110.1016/j.jddst.2018.03.021 ↗
18. 10.1002/jps.2415910.1002/jps.24159 ↗
19. 10.1021/cm402136z10.1021/cm402136z ↗
20. 10.1039/C4CS00101J10.1039/C4CS00101J ↗
21. 10.1016/j.ccr.2020.21325610.1016/j.ccr.2020.213256 ↗
22. 10.1002/anie.20191229610.1002/anie.201912296 ↗
23. 10.1021/acsnano.8b0352910.1021/acsnano.8b03529 ↗
24. 10.1016/j.actbio.2019.06.01410.1016/j.actbio.2019.06.014 ↗
25. 10.1039/C4CC04712E10.1039/C4CC04712E ↗
26. 10.1016/j.actbio.2020.09.01910.1016/j.actbio.2020.09.019 ↗
27. 10.1021/acsami.8b1281210.1021/acsami.8b12812 ↗
28. 10.2147/IJN.S14606410.2147/IJN.S146064 ↗
29. 10.1021/cr200256v10.1021/cr200256v ↗
30. 10.1080/17425247.2016.122929810.1080/17425247.2016.1229298 ↗
31. 10.1002/adma.20170763410.1002/adma.201707634 ↗
32. Wu M. X. · Adv. Mater. · 2017 · 29
33. 10.1016/j.ccr.2022.21473510.1016/j.ccr.2022.214735 ↗
34. 10.1016/j.cej.2021.13020210.1016/j.cej.2021.130202 ↗
35. 10.1016/j.molstruc.2023.13707110.1016/j.molstruc.2023.137071 ↗
36. 10.1016/j.molstruc.2023.13690710.1016/j.molstruc.2023.136907 ↗
37. 10.1016/j.jhazmat.2017.05.02610.1016/j.jhazmat.2017.05.026 ↗
38. 10.1039/D0BM02136A10.1039/D0BM02136A ↗
39. 10.1039/C9TB01994D10.1039/C9TB01994D ↗
40. 10.1002/adma.20230338810.1002/adma.202303388 ↗
41. 10.1016/j.matdes.2022.11136310.1016/j.matdes.2022.111363 ↗
42. 10.1002/adma.20220796110.1002/adma.202207961 ↗
43. 10.1002/adma.20230778510.1002/adma.202307785 ↗
44. 10.1007/s11426-019-9680-610.1007/s11426-019-9680-6 ↗
45. 10.1016/j.actbio.2019.12.03710.1016/j.actbio.2019.12.037 ↗
46. 10.1038/s41467-022-34248-y10.1038/s41467-022-34248-y ↗
47. 10.1021/acsnano.8b0938710.1021/acsnano.8b09387 ↗
48. 10.1002/advs.20210607110.1002/advs.202106071 ↗